Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial

Bibliographic Details
Main Authors: Ziegler, Dan, Low, Phillip A., Litchy, William J., Boulton, Andrew J.M., Vinik, Aaron I., Freeman, Roy, Samigullin, Rustem, Tritschler, Hans, Munzel, Ullrich, Maus, Joachim, Schütte, Klemens, Dyck, Peter J.
Format: Online
Language:English
Published: American Diabetes Association 2011
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161301/
id pubmed-3161301
recordtype oai_dc
spelling pubmed-31613012012-09-01 Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial Ziegler, Dan Low, Phillip A. Litchy, William J. Boulton, Andrew J.M. Vinik, Aaron I. Freeman, Roy Samigullin, Rustem Tritschler, Hans Munzel, Ullrich Maus, Joachim Schütte, Klemens Dyck, Peter J. Original Research American Diabetes Association 2011-09 2011-08-19 /pmc/articles/PMC3161301/ /pubmed/21775755 http://dx.doi.org/10.2337/dc11-0503 Text en © 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Ziegler, Dan
Low, Phillip A.
Litchy, William J.
Boulton, Andrew J.M.
Vinik, Aaron I.
Freeman, Roy
Samigullin, Rustem
Tritschler, Hans
Munzel, Ullrich
Maus, Joachim
Schütte, Klemens
Dyck, Peter J.
spellingShingle Ziegler, Dan
Low, Phillip A.
Litchy, William J.
Boulton, Andrew J.M.
Vinik, Aaron I.
Freeman, Roy
Samigullin, Rustem
Tritschler, Hans
Munzel, Ullrich
Maus, Joachim
Schütte, Klemens
Dyck, Peter J.
Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
author_facet Ziegler, Dan
Low, Phillip A.
Litchy, William J.
Boulton, Andrew J.M.
Vinik, Aaron I.
Freeman, Roy
Samigullin, Rustem
Tritschler, Hans
Munzel, Ullrich
Maus, Joachim
Schütte, Klemens
Dyck, Peter J.
author_sort Ziegler, Dan
title Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
title_short Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
title_full Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
title_fullStr Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
title_full_unstemmed Efficacy and Safety of Antioxidant Treatment With α-Lipoic Acid Over 4 Years in Diabetic Polyneuropathy: The NATHAN 1 trial
title_sort efficacy and safety of antioxidant treatment with α-lipoic acid over 4 years in diabetic polyneuropathy: the nathan 1 trial
description
publisher American Diabetes Association
publishDate 2011
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161301/
_version_ 1611472267920801792